Van Vliet A I, Van Alderwegen I E, Baelde H J, de Heer E, Killen P D, Kalluri R K, Bruijn J A, Bergijk E C
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
J Pathol. 1999 Oct;189(2):279-87. doi: 10.1002/(SICI)1096-9896(199910)189:2<279::AID-PATH428>3.0.CO;2-J.
The expression of collagen type IV chains in the renal tubulointerstitium was investigated during the development of chronic serum sickness (CSS) in rats, a model for immune complex-mediated renal disease. Immunohistochemical studies showed increased expression of alpha4(IV) collagen early during disease development, followed by an increase in alpha1(IV) through alpha3(IV) collagen subchain expression, especially in the tubular basement membrane. Dot-blot and in situ hybridization analysis showed a transient increase in steady-state mRNA levels for all collagen IV subchains during the development of CSS, which was most abundant for alpha1(IV), alpha2(IV), and alpha4(IV). Statistical correlations were found between the mRNA levels of alpha1(IV) and alpha2(IV) collagen and between alpha3(IV) and alpha4(IV), in line with the results of others which showed that these chains are co-distributed as heterotrimer collagen type IV molecules. However, additional correlations were found between the mRNA levels coding for alpha1(IV) and alpha3(IV) collagen, and between alpha1(IV) and alpha4(IV) mRNAs in the course of CSS. These abnormal correlations support the hypothesis that changes occur in the co-expression of the collagen IV subchains during the development of CSS. In addition, a strong correlation was found between the presence in the tubulointerstitium of alpha1(IV) and alpha2(IV) collagen chains, on the one hand, and the tubulointerstitial influx of R73+ and ED1+ cells, on the other, suggesting the involvement of inflammatory cells in the observed alterations in matrix production. Changes in the relative abundance of collagen IV chains in disease states may perturb the collagen IV network in the tubulointerstitial compartment and thereby play a role in the development of renal failure.
在大鼠慢性血清病(CSS)(一种免疫复合物介导的肾脏疾病模型)的发展过程中,对肾小管间质中IV型胶原链的表达进行了研究。免疫组织化学研究表明,在疾病发展早期,α4(IV)胶原的表达增加,随后α1(IV)至α3(IV)胶原亚链的表达增加,尤其是在肾小管基底膜。斑点印迹和原位杂交分析显示,在CSS发展过程中,所有IV型胶原亚链的稳态mRNA水平均短暂升高,其中α1(IV)、α2(IV)和α4(IV)最为丰富。发现α1(IV)和α2(IV)胶原的mRNA水平之间以及α3(IV)和α4(IV)之间存在统计学相关性,这与其他研究结果一致,表明这些链作为IV型异源三聚体胶原分子共分布。然而,在CSS过程中,还发现了编码α1(IV)和α3(IV)胶原的mRNA水平之间以及α1(IV)和α4(IV) mRNA之间的额外相关性。这些异常相关性支持了在CSS发展过程中IV型胶原亚链共表达发生变化的假说。此外,一方面发现α1(IV)和α2(IV)胶原链在肾小管间质中的存在与另一方面R73+和ED1+细胞的肾小管间质内流之间存在强烈相关性,这表明炎症细胞参与了观察到的基质产生变化。疾病状态下IV型胶原链相对丰度的变化可能扰乱肾小管间质区室中的IV型胶原网络,从而在肾衰竭的发展中起作用。